News by Industry

Biotechnology

Releases published in the last 30 days.

Page 1 of 2

In one aspect of vision, computers catch up to primate brain
12/19/2014 9:41:32 AM
For decades, neuroscientists have been trying to design computer networks that can mimic visual skills such as recognizing objects, which the human brain does very accurately and quickly. Until now, no computer model has been able to match the primate brain at visual object recognition during a brief glance. However, a new study from MIT neuroscientists has found that one of …
Neuroscientists identify brain mechanisms that predict generosity in children
Neuroscientists identify brain mechanisms that predict generosity in children
12/19/2014 9:28:57 AM
University of Chicago developmental neuroscientists have found specific brain markers that predict generosity in children. Those neural markers appear to be linked to both social and moral evaluation processes. There are many sorts of prosocial behaviors. Although young children are natural helpers, their perspective on sharing resources tends to be selfish. Jean Decety , …
Toshiba Opens Healthcare Technology Center and Enhances its Research and Development System in the Healthcare Business
Toshiba Opens Healthcare Technology Center and Enhances its Research and Development System in the Healthcare Business
12/17/2014 7:47:32 PM
Toshiba Corporation (Tokyo: 6502) today announced that it has opened the Healthcare Technology Center in the Komukai Complex in Kawasaki city, Kanagawa prefecture today. The center is established for the purpose of expanding the healthcare business under the medium-term management plan, and will serve as a base for the development of next-generation products as well as …
FDA allows marketing of the first newborn screening test to help detect Severe Combined Immunodeficiency
12/16/2014 9:52:43 AM
The U.S. Food and Drug Administration today allowed marketing of the EnLite Neonatal TREC Kit, the first screening test permitted to be marketed by FDA for Severe Combined Immunodeficiency (SCID) in newborns. According to the Centers for Disease Control and Prevention, approximately 40 to100 new cases of SCID are identified in newborns in the United States each year. SCID …
Durable, Colorable, Silky TPSiV® Elastomers from Dow Corning Show Favorable Results when Tested for Prolonged Skin Contact.
12/15/2014 9:03:28 AM
Dow Corning, a global leader in silicones, silicon-based technology and innovation, announced today that its TPSiV ® 4000 and TPSiV ® 4200 Thermoplastic Elastomers (TPEs) have been tested according to United States Pharmacopeia’s (USP) General Chapter -88- and ISO 10993-10 guidelines and have shown to be non irritating and non sensitizing in skin contact applications. The …
12/14/14 EDITORIAL: Independent Author Salvatore Ingoglia Junior’s New Release for New Year 2015
12/15/2014 1:00:00 AM
The New Year 2015 is quickly approaching and it is important to head into the New Year with a brand new mind set and willingness to improve ones marriage and relationship with ones partner. Introducing Salvatore Ingoglia JR, and his new independent Release ‘ How to save your marriage: Applying spiritual ways that allow you to know how to improve your marriage. Salvatore …
Sobi CEO Geoffrey McDonough sells a portion of 2014 incentive shares
12/9/2014 8:53:22 AM
During the first week of December 2014 Sobi’s CEO Geoffrey McDonough sold 350,000 of the shares he holds in Sobi. The sale was made in order to cover the estimated US tax liability for both the company’s CEO incentive share programme, which vested in September 2014, and for the vesting in mid-December 2014 of the company’s 2011 long-term incentive programme. This is the first …
Birmingham to lead pioneering study to test new treatment for Sjogren’s syndrome
12/8/2014 11:57:20 AM
The National Institute for Health Research (NIHR) has today announced the start of the UK’s first commercial trial of a new treatment for Sjogren’s syndrome. Up to half a million people in the UK are affected by the autoimmune condition. The study will test a new antibody treatment, which has the potential to bring relief to sufferers with Sjogren’s syndrome, a condition …
Roche launches next-generation viral load testing assays for new molecular diagnostic platforms in markets accepting the CE mark
12/8/2014 11:53:25 AM
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the commercial availability of the cobas® HIV-1 and cobas HCV assays for use on the cobas 6800/8800 Systems—expanding the menu on the newest molecular diagnostic platforms from Roche with next generation viral load monitoring assays. The new assays offer the high performance that clinicians depend on to manage the treatment …
Memorial Sloan Kettering Study Shows New Kind of Targeted Drug Has Promise for Leukemia Patients
12/8/2014 8:34:19 AM
A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial. The study, led by Eytan M. Stein, MD , a medical oncologist at Memorial Sloan Kettering Cancer Center, was presented today at the 56th Annual Meeting of the American Society of Hematology. Approximately 15 percent of …
New microscope technology revolutionizes skin-aging research
12/5/2014 6:50:23 PM
Further advancement with the Nobel Prize winning STED technology allows new findings on skin aging Research is the basis for the development of skin care products that can stop or reverse the structural changes of the skin The awarding of the Nobel Prizes on December 10th will be cause for special celebration this year for Beiersdorf researchers because this time the …
Basilea announces launch of antibiotic Zevtera® (ceftobiprole medocaril) in Germany
12/5/2014 1:02:56 PM
Basilea Pharmaceutica Ltd. (SIX: BSLN) announces today that its broad-spectrum antibiotic, Zevtera® (ceftobiprole medocaril)* has been launched in Germany. The European Centre for Disease Prevention and Control (ECDC) estimates that every year approximately 25,000 people die from antibiotic-resistant healthcare-associated infections in the European Union.1 The new …
American Association for Cancer Research Recognizes Dr. Mary-Claire King With 2014 Distinguished Lectureship in Breast Cancer Research
12/5/2014 12:26:05 PM
Mary-Claire King, PhD, the American Cancer Society professor in the Departments of Medicine (Medical Genetics) and Genome Sciences at the University of Washington School of Medicine in Seattle, is being honored with the Seventh Annual American Association for Cancer Research (AACR) Distinguished Lectureship in Breast Cancer Research, at the 2014 San Antonio Breast Cancer …
Carnegie Mellon Researchers Discover Brain Representations of Social Thoughts Accurately Predict Autism Diagnosis
Carnegie Mellon Researchers Discover Brain Representations of Social Thoughts Accurately Predict Autism Diagnosis
12/2/2014 5:42:22 PM
Psychiatric disorders — including autism — are characterized and diagnosed based on a clinical assessment of verbal and physical behavior. However, brain imaging and cognitive neuroscience are poised to provide a powerful advanced new tool. Carnegie Mellon University researchers have created brain-reading techniques to use neural representations of social thoughts to predict …
AstraZeneca and Eli Lilly and Company initiate pivotal clinical trial for patients with early Alzheimer’s disease
12/1/2014 10:40:50 AM
AstraZeneca and Eli Lilly and Company (Lilly) today announced enrolment of the first patient into AMARANTH, a Phase II/III study of an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer’s disease. AZD3293, also known as LY3314814, has been shown in Phase I studies to reduce levels of amyloid-beta in the …
Toshiba Corporation launches genotyping service using Japonica Array™, a Japanese population genotyping array
Toshiba Corporation launches genotyping service using Japonica Array™, a Japanese population genotyping array
12/1/2014 10:37:05 AM
Toshiba Corporation (Tokyo: 6502) today launched a genotyping service for universities, hospitals, pharmaceutical companies and other research organizations. The service employs Japonica Array™, a genotyping array optimized for ethnic Japanese. Japonica Array™, the focal point of the service, facilitates genome sequencing and genotyping of blood, saliva or DNA samples, which …
New MRI scanner combines cutting-edge technology with reduced operating costs
New MRI scanner combines cutting-edge technology with reduced operating costs
12/1/2014 10:30:10 AM
Siemens Healthcare has expanded its portfolio of magnetic resonance imaging (MRI) systems to include the 1.5-tesla scanner Magnetom Amira(1). The new MRI scanner offers the same technologies that are available on the Siemens flagship MRI systems. Magnetom Amira also stands out against other scanners on account of its lower operating costs. One reason is the new "Eco-Power" …
Neuronetics Appoints Christopher Thatcher as President and Chief Executive Officer
12/1/2014 8:00:00 AM
Malvern, Pennsylvania, December 1, 2014 – Neuronetics, Inc., the pioneering leader in Transcranial Magnetic Stimulation therapy to treat Major Depressive Disorder announced today that Christopher Thatcher has joined the company as President and Chief Executive Officer. “Chris offers a diversified skillset with extensive experience in both traditional medical device and …
Philips introduces patient-centric solution designed to help patients relax during MRI scans
11/28/2014 4:16:26 PM
  Royal Philips (NYSE: PHG, AEX: PHIA) today announced the launch of the  Ambient Experience patient in-bore solution  designed to reduce patient anxiety and movement during magnetic resonance imaging (MRI) examinations. The patient in-bore solution is the latest innovation in  Philips’ successful Ambient Experience  portfolio, which integrates dynamic lighting, projection, …
NIAID/GSK experimental Ebola vaccine appears safe, prompts immune response
NIAID/GSK experimental Ebola vaccine appears safe, prompts immune response
11/28/2014 8:50:45 AM
An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a phase 1 clinical trial conducted by researchers from the National Institutes of Health. The candidate vaccine, which was co-developed by the NIH’s National Institute of Allergy and Infectious Diseases (NIAID) and …